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Human Osteoblast-Derived Extracellular Matrix
with High Homology to Bone Proteome Is Osteopromotive
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Efficient osteogenic differentiation of mesenchymal stromal cells (MSCs) is crucial to accelerate bone for-
mation. In this context, the use of extracellular matrix (ECM) as natural 3D framework mimicking in vivo tissue
architecture is of interest. The aim of this study was to generate a devitalized human osteogenic MSC-derived
ECM and to investigate its impact on MSC osteogenic differentiation to improve MSC properties in bone
regeneration. The devitalized ECM significantly enhanced MSC adhesion and proliferation. Osteogenic dif-
ferentiation and mineralization of MSCs on the ECM were quicker than in standard conditions. The presence of
ECM promoted in vivo bone formation by MSCs in a mouse model of ectopic calcification. We analyzed the
ECM composition by mass spectrometry, detecting 846 proteins. Of these, 473 proteins were shared with the
human bone proteome we previously described, demonstrating high homology to an in vivo microenvironment.
Bioinformatic analysis of the 846 proteins showed involvement in adhesion and osteogenic differentiation,
confirming the ECM composition as key modulator of MSC behavior. In addition to known ECM components,
proteomic analysis revealed novel ECM functions, which could improve culture conditions. In summary, this
study provides a simplified method to obtain an in vitro MSC-derived ECM that enhances osteogenic differ-
entiation and could be applied as natural biomaterial to accelerate bone regeneration.
Keywords: mesenchymal stromal cells, extracellular matrix, bone, bone tissue engineering
Introduction
Mesenchymal stromal cells (MSCs) are promisingcandidates for bone regeneration, because they can
differentiate toward osteoblasts and secrete trophic factors
that modulate target cells.1,2 MSCs are combined with
biomaterials for bone tissue engineering applications, and
have been proposed to reduce skeletal defects.3
Toaccelerate bone regeneration,differentiationofMSCs into
bone-forming cells is critical. In vivo, MSC-derived osteoblasts
deposit the surrounding extracellular matrix (ECM) that is
subsequently mineralized.4 The most abundant protein of the
ECM is collagen type 1 (COL1A1). Together with hydroxy-
apatite crystals, the ECM physically supports bone cells to
regulate mineral deposition.
Furthermore, the bone ECM is a very dynamic tissue that
contains and actively regulates the availability of growth
factors (GFs) and signaling factors, such as bone morpho-
genic proteins (BMPs), and influences the signal transduction
of these molecules. As a result, the ECM modulates MSC
behavior, such as cell adhesion, proliferation, and commit-
ment.5,6 The specific composition of bone ECM is essential in
this role. This is because proteoglycans and enzymes such as
alkaline phosphatase (ALP) and matrix metalloproteinases
(MMPs) enrich the ECM composition, along with the non-
collagenous proteins (NCPs), such as osteonectin (SPARC),
osteocalcin (BGLAP), osteopontin, and matrix gla proteins,
which regulate collagen–fiber mineralization and cell–matrix
adhesion.5
Recently, the ECM has become increasingly important as
a natural 3D framework, which modulates cell behavior and
mimics the in vivo tissue architecture.7,8 Strategies com-
bining ECM-coated scaffolds and MSCs have been pro-
posed to improve the supportive role of scaffolds in bone
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regeneration.9 In this context, in vitro cell-secreted ECMs
have been produced according to several decellularization
methods, and represent a suitable alternative to decellular-
ized matrices from tissues.10
Cell-derived ECMs have been proposed for extensive
ex vivo expansion of MSCs, as they promote proliferation
and maintain the multilineage differentiation potential of
MSCs.11–13 Interestingly, osteoblast-derived ECM enhances
the osteogenesis of MSCs.14,15 Although known ECM com-
ponents such as collagen, fibronectin (FN), laminin, perlecan,
biglycan, and decorin were detected in these MSC-derived
ECMs, their full composition is still under investigation.12,16–19
Nevertheless, the specific protein composition of ECM medi-
ates these effects through cell–matrix interactions; for instance,
COL1A1 and vitronectin (VTN) promote osteogenesis, and
FN influences MSC behavior.6,20–22 However, key ECM bio-
active regulators of MSC functions have not yet been
identified. The full composition of the ECM is difficult to
disentangle due to its complex structure.
The aim of this study was to generate a devitalized ECM
from human osteoblast-differentiated MSCs and investigate
its effect on the osteogenic differentiation of MSCs and
bone formation in vivo. The protein composition of the
ECM was investigated by mass spectrometry (MS) and
compared with the human bone proteome,23 to gain insight
into how the ECM modulates MSC behavior and whether it
mimics the in vivo bone microenvironment.
Materials and Methods
Culture and devitalization of MSCs
Human bone marrow-derived MSCs were obtained
commercially (PT-2501; Lonza, Walkersville, MD). MSCs
from a single donor at passage 7 were cultured in 12-well
plates (5128 cells/cm2; Greiner bio-one, Frickenhausen,
Germany) in alpha-Mem (10% fetal bovine serum (FBS),
pH 7.5, phenol-red free, Gibco BRL, Life technologies).
After 2 days of culture in non-differentiating conditions,
MSCs were cultured in osteogenic conditions for 11 days
(medium was supplemented with 100 nM dexamethasone
and 10mM b glycerophosphate; Sigma-Aldrich, St. Louis,
MO) to induce the osteogenic differentiation.
Before the onset of mineralization, MSCs were devita-
lized as represented in Figure 1A. In brief, MSCs were
washed twice with phosphate-buffered saline (PBS; Gibco
BRL, Carlsbad, CA), frozen at -80C, and then thawed at
room temperature, without PBS, for 20min each. These
steps were repeated three times and followed by a DNase I
treatment for 30min at 37C (10U/mL; Sigma-Aldrich).
The devitalized matrix was gently rinsed three times with
PBS, air dried in the culture hood, and stored at -20C for at
least 7 days before further experiments.
ECM characterization
The devitalized ECM was cultured in osteogenic medium
for 6, 24, and 48 h and the metabolic activity of the devi-
talized ECM was assessed by a viability indicator (Presto
Blue Cell Viability Agent; Life Technologies) following
manufacturer’s instructions. Fluorescence was measured by
a microplate reader (Victor X4 Multimode Plate Reader,
Perkin Elmer; excitation 530 nm, emission 590 nm). Live
MSCs cultured in osteogenic conditions were used as pos-
itive control.
The absence of cells after the devitalization treatment was
demonstrated by 4,6-diamidino-2-phenylindole (DAPI) nu-
clear staining (Sigma-Aldrich). MSCs cultured on plastic
and on ECM for 24 h were used as positive control.
To measure the roughness, the matrix was produced on
glass coverslips coated with poly-L-lysine (PLL) (Sigma-
Aldrich), following the devitalization procedure. In brief,
sterile glass coverslips had been coated with PLL for 10min
and washed three times with milliQ water before cell seeding.
For the background measurements, the same treatment was
applied to a coated coverslip without cells. A dynamic mode
atomic force microscopy (AFM; NaniteAFM, Nanosurf
GmbH, Germany) was used to measure the roughness of the
ECM. Areas of 50 · 50mm, 20 · 20mm, and 5 · 5mm were
scanned in two different areas of the matrix surface with
noncontact long cantilever reflex coating (NCLR) probes
(Nanoworld AG, Switzerland). Images of 20 · 20mm scanned
areas were analyzed using Gwyddion.*
We quantified the roughness by drawing eight lines across
each image and considering the amplitude of Roughness
average (Ra) for each line, which is defined as the average
deviation of all points of roughness profile from a mean line
over the evaluation length. The Ra values of all the lines
were eventually averaged to the final values. Measurements
were representative of two independent experiments.
The surface of the devitalized ECM was imaged by scan-
ning electron microscopy (SEM) using a JEOL JSM-IT100LA
equipment (JEOL Europe BV, Nieuw-Vennep, The Nether-
lands). Samples were prepared as previously described.24 In
brief, devitalized ECM on PLL-coated coverslip was washed
with PBS, fixed (4% paraformaldehyde, 1% glutaraldehyde in
PBS, pH 7.4), rinsed in demineralized water, dehydrated se-
quentially in graded alcohols (50% for 15min, 70% for 20min,
96% for 20min), air dried, and gold coated. Different areas of
two replicates were examined at various magnifications.
Cell adhesion analysis
To observe the cell morphology and analyze the cell ad-
hesion to the ECM by immunohistochemistry, the devitalized
ECM was produced on polystyrene plastic. Next, MSCs in
osteogenic conditions were cultured for 2, 4, and 8 h. Actin
cytoskeleton was stained by rhodamine-conjugated phalloi-
din (ThermoFisher Scientific); focal adhesionswere observed
by staining vinculin (Vinculin Abfinity recombinant rabbit
monoclonal antibody, Clone 42H89 L44, Life Technology; as
secondary antibody: FITC goat antirabbit IgG, BD Pharmi-
gen) and observed by a fluorescent microscope (Zeiss Ax-
iovert 200MOTmicroscope). Images with a magnification of
630· were considered and processed with Image J (www.
imagej.nih.gov/ij, version 1.47n), as previously described.25
In brief, the background was subtracted by using the
Sliding Paraboloid option, the local contrast was enhanced
by running the Clahe option, the Mathematical Subtract
Function with a value of 10,000 was applied to subtract the
background, followed by Mathematical Exponential (EXP)
to further minimize the background. The contrast was ad-
justed using Brightness & Contrast tool. The number of
*www.gwyddion.net
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focal adhesions relative to the area stained by phalloidin was
quantified by Cell Profiler (www.cellprofiler.com, version 2.
1.1). For the analysis, an average of four pictures with a
magnification of 400·was considered, following the same
steps as previously described with Image J, and analyzed
using a self-made pipeline in Cell Profiler.
The morphology of cells cultured on the devitalized ECM
and in standard culture conditions on PLL-coated coverslips
was observed by SEM. Cells were cultured in osteogenic
conditions for 24 h and processed as previously described24 for
the devitalized ECM. Images were acquired at various mag-
nifications using secondary and backscattered imaging modes.
Cell adhesion was quantified by Flow Cytometry (Accuri
C6 Flow Cytometer; BD Biosciences, San Jose, CA), using
counting beads (Liquid Counting Beads; BD Biosciences).
MSCs in osteogenic conditions were cultured for 6 and 24 h
on ECM and plastic; after washing and trypsinization, the
number of cells relative to a known concentration of fluo-
rescent counting beads was counted. The result is repre-
sentative of three independent experiments.
The heterogeneous MSC population was sorted based
on ALP expression by fluorescence-activated cell sorting
(FACS) (FACS Jazz; BD Bioscience) (ALP antibody: PE
mouse antihuman ALP, clone B4-78; BD Biosciences). ALP-
positive and ALP-negative sorted cells were seeded on the
devitalized ECM in osteogenic medium, and cell adhesion
was measured after 24 h of culture as previously described.
Unsorted MSCs were used as control. Measurements were
representative of two independent FACS experiments.
Cell proliferation analysis
For the measurement of proliferation, MSCs were cul-
tured in osteogenic conditions on ECM and plastic dishes
for 1, 3, and 5 days, and the percentage of Ki-67 positive
cells was detected (Alexa Fluor 488 mouse antihuman Ki-
67; BD Pharmigen) by Flow Cytometry (Accuri C6 Flow
Cytometer; BD Biosciences), within the propidium iodide-
positive population (PI solution; BD Biosciences). The re-
sult is representative of three independent experiments.
Culture of MSCs on ECM and analysis
of osteogenic differentiation
ALP activity and ECMmineralization were measured in cell
extracts ofMSCs cultured in osteogenic conditions on ECMand
plastic dishes for 19 days as previously described.26 Miner-
alizationwas further confirmedbyAlizarin red staining (ARS).26
The result is representative of three independent experiments.
In vivo ectopic bone formation analysis
To check whether the ECM would promote in vivo ectopic
bone formation by MSCs, MSCs on hydroxyapatite and tri-
calciumphosphate beta (HA-TCP)with andwithoutECMhave
been subcutaneously implanted in immunocompromised mice
(nonobese diabetic/Scid IL2R gamma (NSG), Charles River
Laboratories). ECMwas produced and devitalized on 20mg of
HA-TCP (Triosite; Zimmer Biomet, Warsaw, IN) powder,
following the same devitalization procedure as previously de-
scribed.
HA-TCPs were loaded with MSCs (0.5 · 106/HA-TCP-
pellet) in growth medium, let them attach overnight and
subcutaneously implanted into four dorsal pockets in NSG
mice (N = 3) (10 weeks old, females and males) under an-
esthesia, as previously described.27 ECM on HA-TCP and
HA-TCP vehicle were used as controls. A schematic over-
view is presented in Figure 4A. Three independent experi-
ments with similar sample size were performed. All animal
procedures were approved by the Committee on the Ethics
of Animal Experiments of Erasmus University Medical
Center, Rotterdam, The Netherlands. Mice were kept in
pathogen-free facility, with 12 h/12 h light/dark cycle, con-
trolled temperature (22C– 1C) and humidity (50% – 5%),
and fed ad libitum with standard rodent diet.
All pellets were retrieved 8 weeks after implantation and
ectopic calcificationwas checked byMasson–Goldner staining.
In brief, pellets were fixed in 70% ethanol, dehydrated in gra-
ded alcohols, plastic embedded (methyl methacrylate, MMA),
and cut into 6-mm-thick sections by microtome (RM2255;
Leica Biosystem). Two stained sections of each pellet (one
from the periphery of the pellet and one from the core) were
scanned byNanozoomer 2.0 HT (Hamamatsu Photonics), and
areas of newly formed mineralized bone over HA-TCP were
quantified by Image J (www.imagej.nih.gov/ij, version 1.47n),
by two independent observers blind toward the data (as re-
presented in Supplementary Fig. S1A–C. Supplementary Data
are available online at www.liebertpub.com/tea).
MS analysis
The proteomic composition of ECM was analyzed by MS,
with a label-free quantification (LFQ) method. ECM samples
were scraped and collected in 0.5mL of PBS Triton 0.1% and
concentrated by using centrifugal filters (AmiconUltra-0.5mL
centrifugal filters, Millipore; 3KDa cutoff) following manu-
facturer’s instructions. Protein content was quantified by BCA
kit (Pierce Biotechnology, Rockford, IL) following manufac-
turer’s instruction. Protein extracts (2.5mg) were reduced by
NuPAGE reducing agent and resolved by one-dimensional
SDS-Page gel, in duplicate (NuPAGENovex 4–12% Bis-
Tris-Acetate Gels; Life technologies). Protein bands were
stained with Coomassie staining (Bio-safe Coomassie; Bio-
Rad, Hercules, CA) for 1 h and destained in milliQ water
overnight. Samples were processed as previously described.28
In brief, an automatic gel slicer was used to cut gel lanes
into 2-mm slices, which were subsequently in-gel reduced
with dithiothreitol, alkylated with iodoacetamide, and di-
gested with trypsin (Promega, sequencing grade, Madison,
WI). A 1100 series capillary LC system (Agilent Technol-
ogies) coupled to an LTQ-Orbitrap XL mass spectrometer
(Thermo Scientific) was used in positive mode to perform
Nanoflow LC-MS/MS. ReproSil C18 reversed phase column
(Dr. Maisch GmbH; 1.5 cm · 100 mm, packed in-house) was
used to trap the peptide mixtures at a flow rate of 8 mL/min.
Peptides were separated by a linear gradient from 0%
to 80% B (A = 0.1% formic acid; B = 80% (v/v) acetoni-
trile, 0.1% formic acid) in 170min, at a constant flow rate
of 200 nL/min, using a splitter, on ReproSil C18 reversed
phase column (Dr. Maisch GmbH; Ammerbuch-Entringen,
GE; 15 cm · 50 mm, packed in-house). The eluent was di-
rectly sprayed from the column into the ESI source of the
mass spectrometer. Peptides were fragmented in data-
dependent mode, and mass spectra were acquired in continuum
mode. The MS proteomics data have been deposited to the
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ProteomeXchange Consortium through the PRIDE29 partner
repository with the data set identifier PXD006865 (Username:
reviewer20352@ebi.ac.uk; Password: LC3okFPV).
Bioinformatic analysis
The MaxQuant Software (version 1.5.0.0) was used to an-
alyze the raw MS data, with a false discovery rate of 0.01 for
proteins and peptides and six amino acids asminimumpeptide
length. The MS/MS spectra were searched by Andromeda
search engine, against the human proteome as provided
by Uniprot database (taxonomy: Homo sapiens, release
HUMAN_2013_04) (uniprot.org, v2014_05), with the re-
versed versions of all the sequences (maximum of two
missed cleavages; 0.6 Da fragment mass tolerance, enzyme
specificity: trypsin). Samples were run in duplicates and then
averaged for the analysis. LFQ values >0 were considered for
the analysis. Over-represented gene ontology (GO) terms were
analyzed by using DAVID Bioinformatic Resources v6.7,30
using the whole human genome as background. Only signifi-
cantly enriched terms (Benjamini p< 0.01) were considered.
The protein composition of the devitalized ECM was com-
pared with one of three human bone samples that we previously
described.23 The shared proteins between the two data sets were
analyzed through QIAGEN’s Ingenuity Pathway Analysis
(IPA, QIAGEN Redwood City www.qiagen.com/ingenuity).
Immunoblot analysis
The presence of some proteins detected by MS in the ECM
was confirmed by Western blot. In brief, ECM samples (12mg)
were prepared as for MS analysis, mixed with 6· reducing
sample buffer, separated by SDS-PAGE, and transferred onto
nitrocellulosemembrane (Hybond-ECL;AmershamBioscience,
Buckinghamshire,UnitedKingdom).After nonspecific blocking
with 5% BSA in Tris-buffered saline 0.1% Tween-20, mem-
branes were incubated overnight with primary antibody against
FN1 (mousemonoclonal to FN1, 1:5000, Ab-11, Clone FBN11;
TermoFisherScientific,Rockford, IL),ALP(mousemonoclonal
to ALP, 1:1000, Clone 0.G.2; Abcam, Cambridge, United
Kingdom), ANXA2 (rabbit polyclonal, 1:1000; Abcam), and
GAPDH loading control (mouse monoclonal, 1:1000, Clone sc-
69778; Santa Cruz Biotechnology, Dallas, TX).
Membranes were probed with secondary antibody conju-
gated with goat antimouse Alexa Fluor 680 (goat antimouse,
1:300; Invitrogen, Waltham, MA) and IRDye 800CW (goat
antirabbit, 1:5000; LI-COR, Lincoln, NE). Bands were
observed using the LI-COR Infrared Imaging System (LI-
COR) according to manufacturer’s instruction.
Statistical analysis
Data are representative of multiple independent experi-
ments. All values are presented as average – standard devi-
ation (SD) of biological replicates, and significance was
calculated by two-way analysis of variance, followed by
Bonferroni Post Hoc test, otherwise indicated elsewhere.
Results
Preparation of MSC-derived ECM
To study the impact of the ECM on MSC behavior, we
successfully produced an in vitro model of devitalized ECM
by using freeze/thaw cycling as decellularization technique.
As schematically represented in Figure 1A, MSCs were
osteogenically differentiated to allow the production of the
ECM, and before the onset of mineralization, devitalized by
freeze/thaw cycles, followed by a DNAse treatment. Ex-
tensive washings were intended to withdraw the potential
remaining live cells and the cellular debris. Taking advantage
of an adaptation of a previous protocol,31 this devitalization
procedure represented a simplified way of producing an
in vitro cell-secreted ECM.
The ECM was metabolic inactive after the devitalization
treatment and exhibited a rough surface
As the devitalization treatment should remove cells to
minimize immune response, while maintaining the bioac-
tivity of the matrix,9 we checked the efficacy of the devita-
lization treatment by using Presto Blue. Figure 1B illustrates
that the devitalization treatment completely abolished the
viability of the cells. In fact, although the metabolic ac-
tivity of live MSCs increased over time as expected, the
matrix remained metabolically inactive. DAPI nuclear
staining showed that cells were absent after devitalization
treatment (Supplementary Fig. S1D). This confirmed the
validity of the devitalization treatment used to prepare the
MSC-derived ECM.
Next, we analyzed the surface of the devitalized ECM by
AFM. AFM images of the scanned areas showed that the
matrix had a rough surface, and exhibited fiber-like struc-
tures relative to the featureless PLL-coated surfaces
(Fig. 1C). Quantified data revealed a roughness of 12.75 nm
for the ECM compared with 4.53 nm for the PLL-coated
surface without cells, as shown in Figures 1C, D. In-
vestigations of larger areas of devitalized ECM by SEM
confirmed the rough surface and the presence of fibrous
structures and aggregates (Fig. 1E).
The ECM increased MSC adhesion
Next, we investigated whether the devitalized ECM could
enhance cellular attachment. Therefore, we analyzed the
effect of the devitalized ECM on the adhesion of freshly
seeded human MSCs.
Figure 2A illustrates that MSCs adhere more efficiently
and quicker on the devitalized ECM than on plastic. Within
2 h after seeding the cells, the actin cytoskeleton was cor-
rectly organized to shape a proper morphology, as shown by
phalloidin staining, whereas this was not yet the case for the
MSCs seeded on plastic. In addition, vinculin staining
showed that MSCs on ECM formed focal adhesions within
2 h after seeding. At this time point, the number of focal
adhesions per area stained by phalloidin in cells on ECM
was >18-fold higher than in cells seeded on plastic. Al-
though not significant, the number of focal adhesions was
overall higher at each time point (Supplementary Fig. S1E).
These analyses illustrate that seeding cells on a preformed
ECM significantly accelerates MSC adhesion.
MSCs cultured for 24 h on the devitalized ECM and in
standard culture conditions exhibited a stretched morphology
with focal adhesion complexes, but no substantial differences
in morphology were highlighted when imaged at high mag-
nification by SEM (Fig. 2B). However, an increased number
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FIG. 1. Preparation and characterization of MSC-derived ECM. (A) Schematic overview of ECM preparation and culture
conditions. (B) Metabolic activity of ECM and live MSCs measured at 6, 24, and 48 h after seeding with Presto Blue
viability agent. Values are presented as relative to blank (osteogenic medium with Presto Blue) (***p < 0.001) (N = 3). (C)
AFM images of ECM and control (20 · 20 mm scans) on a glass substrate. Images represent the topography of the area
analyzed, coming from the oscillation of the cantilever over the scanned surface. Black arrows indicate fiber-like structures.
(D) Roughness quantification of ECM and control, based on amplitude of average roughness (Ra) values from independent
scans. Values: average –SD. (E) Scanning electron micrographs of the surface of devitalized ECM at 200· (left) and 500·
magnification (right). Images are representative for multiple areas in two specimens. Scale bars indicate 100 mm (left) and
50 mm (right). AFM, atomic force microscopy; ECM, extracellular matrix; MSC, mesenchymal stromal cell.
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of cells were generally observed on the devitalized ECM
relative to the standard culture conditions.
The increased cell adhesion was further confirmed by
counting the number of cells that adhere to the different
substrates. Six hours after seeding on the ECM, the number
of cells was 1.2-fold ( p < 0.01) higher than on plastic, and
1.3-fold ( p < 0.05) higher after 24 h (Fig. 2C).
In addition, we investigated the preferential adhesion of
MSC subsets to the devitalized ECM. We focused on ALP-
positive MSCs, considered as already osteogenic committed
FIG. 2. ECM enhances MSC adhesion and proliferation. (A) Immunohistochemistry of MSCs on ECM (top) and plastic
(bottom) at 2, 4, and 8 h after seeding. Red, phalloidin for actin cytoskeleton; green, vinculin of focal adhesions. (B) SEM
images of MSCs cultured on the devitalized ECM (top) and in standard culture conditions (bottom) for 24 h, at 60· (left)
and 500 ·magnification (right). Images are representative of multiple areas in two specimens. Scale bars indicate 200 mm
(left) and 50mm (right). (C) Quantification of cells in adhesion to substrates counted by flow cytometry. (D) Quantification
of MSC subsets (ALP positive-, ALP negative-sorted cells, and unsorted cells) in adhesion to the ECM for 24 h, counted by
flow cytometry (no significant difference was detected by one-way analysis of variance, followed by Bonferroni’s multiple
comparison test). (E) Proliferation of MSCs on ECM and on plastic as percentage of Ki-67-positive cells by flow cytometry.
Results are representative of multiple independent experiments. (*p < 0.05; **p < 0.01; ***p< 0.001). Values: Average –
SD. ALP, alkaline phosphatase. Color images available online at www.liebertpub.com/tea
1382 BARONCELLI ET AL.
D
ow
nl
oa
de
d 
by
 E
ra
sm
us
 M
C 
- R
ot
te
rd
am
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
9/
19
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
MSCs, and ALP-negative MSCs, considered as yet un-
committed MSCs. Hereto we fluorescence-activated cell
sorted the heterogeneous population of MSCs based on ALP
expression, and next seeded the ALP-positive and ALP-
negative population on the devitalized ECM. After 24 h of
culture, no significant difference was detected in the adhe-
sion of these subsets and the unsorted population (Fig. 2D).
The devitalized ECM was able to bind not only the com-
mitted ALP-positive MSCs but also the ALP-negative cells.
The ECM increased MSC proliferation
and accelerated MSC osteogenic differentiation
and mineralization in vitro
We investigated whether the accelerated attachment to
the devitalized ECM was accompanied by an effect on cell
proliferation, by analyzing the percentage of Ki-67-positive
cells by flow cytometry. After 1 day of culture of MSCs on
ECM, 34% of the cells were Ki-67 positive, whereas only
11% of the cells were positive when cultured on plastic.
This illustrates that 24 h of culture on ECM was sufficient to
increase the number of proliferating MSCs by 2.97-fold
(Fig. 2E). The percentage of Ki-67-positive cells gradually
decreased in time to similar levels as the cells seeded on
plastic. After 5 days of osteogenic differentiation, the per-
centage of proliferating cells lowered to 16%.
Next, the influence of the ECM on the osteogenic differ-
entiation of MSCs was studied. MSCs cultured on ECM dif-
ferentiated faster toward osteoblasts than those grown on
plastic. After 11 days of differentiation, ALP activity in MSCs
cultured on ECM was 2.2-fold higher than their counterpart on
plastic (Fig. 3A). Furthermore, mineralization was accelerated
and increased by culturing MSCs on the ECM, as illustrated
by calcium deposition in the well and the ARS (Fig. 3B–D).
The amount of calcium deposited after 19 days of culture, as
measure of mineralization, was >20-fold higher in MSCs
cultured on ECM than on plastic (Fig. 3B). ARS of the min-
eralized ECM confirmed the increased mineralization of cells
seeded on devitalized ECM, as shown in Figure 3C, D.
ECM promoted in vivo ectopic bone
formation by MSCs
Based on the osteopromotive role of the ECM on MSCs
in vitro, we investigatedwhether the ECM influenced the in vivo
bone formation by MSCs in an ectopic calcification model.
MSCs with and without ECM were subcutaneously im-
planted on HA-TCP in immunocompromised mice and bone
FIG. 3. ECM accelerates
MSC osteogenic differentia-
tion and mineralization. (A)
ALP activity in cell extracts
of MSCs on ECM and plas-
tic. (B) Calcium deposition
in cell extracts of MSCs
cultured on ECM and plastic.
The values of MSCs on ECM
were subtracted by the ECM
contribution. All values are
corrected for protein content
at each time point. Negative
values were artificially set as
0. The provided results are
representative of multiple
independent experiments.
(C) Alizarin Red Staining
(ARS) at days 13 and 21 of
culture, in MSCs on plastic
(top), MSCs on ECM (mid-
dle), and ECM only (bottom).
(D) Quantification of ARS at
days 13 and 21 of culture.
(**p< 0.01; ***p < 0.001,
****p < 0.0001). Values:
Average – SD. Color images
available online at www
.liebertpub.com/tea
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formation checked by Masson–Goldner staining after 8 weeks,
as represented in Figure 4A. Histological evaluation showed
that MSCs on HA in this experimental setup induced ectopic
bone formation (Fig. 4B, C). In two out of three experiments,
MSCs implanted with ECM gave rise to about 20-fold higher
amount of bone than when ECM was not present (Fig. 4D). In
the experiment that did not show an effect of ECM, the bone
formation in control HA-TCP was already at the level induced
by the ECM conditions in the other experiments, potentially
explaining that an additional increase was not observed.
Overall, in contrast to the control condition, the presence
of ECM robustly led to ectopic bone formation in all ex-
periments (Fig. 4D). Ectopic bone formation was not de-
tected when HA-TCP pellets were loaded without MSCs
(Supplementary Fig. S1F).
The proteomic composition of the ECM
corroborated the role of the devitalized matrix
in mediating the observed effects on MSCs
Following thesepositive effects of thedevitalizedECMoncell
adhesion, proliferation, and osteogenic differentiation of MSCs,
we investigated the protein composition of the ECM, to identify
candidate proteins and processes underlying these effects. MS
analysis identified 846 proteins that were part of the devitalized
ECM (Supplementary Table S1). Of these 846, 35 proteins were
annotated as ‘‘extracellular matrix’’ GO term (GO:0031012)
(Fig. 5A). The detection of knownECMcomponents such as FN,
COL1A1, and tenascin C (TNC) within the most abundant pro-
teins in the devitalized ECM confirmed the presence of a bone-
like ECM and the validity of the devitalization treatment to
produce theECM.ThepresenceofproteinsdetectedbyMSin the
devitalizedECMsuch asFN,Annexin2 (ANXA2), andALPwas
confirmed by Western blot analysis (Fig. 5B).
As illustrated in Figure 5C, GO analysis revealed that
the top 10% most abundant proteins (85 proteins) were in-
volved in cell–matrix adhesion processes, as integrin bind-
ing (GO:0005178) was significantly enriched. Furthermore,
GO terms such as membrane-bounded vesicle (GO:0031988)
and calcium ion binding (GO:0005509), which included
proteins such as ANXA2, ANXA5, and ANXA6, were also
enriched in our analysis (Supplementary Table S2). As these
proteins are involved in matrix vesicle release, calcium ion
binding, and, therefore, mineralization, this suggested the role
of the ECM in promoting the osteogenic differentiation and
mineralization of MSCs. ALP was also detected and ranked
in position 142 of abundance (Fig. 5A, B and Supplementary
Table S1). However, ALP appeared to be inactive as the
ECM lacked ALP activity (Supplementary Fig. S1G).
The GO analysis of the whole composition of the ECM
shown in Figure 5D illustrates that the GO term ECM organi-
zation (GO:0030198) was significantly enriched, meaning that
the total composition of ECMwas important for the structure of
the devitalized ECM, and not only the most abundant proteins.
Furthermore, Figure 5D illustrates that GO terms such as anti-
oxidant activity (GO:0016209), mitochondrion (GO:0005739),
and vasculature development (GO:0001944) were significantly
enriched (Supplementary Table S3).
FIG. 4. MSCs on ECM on
HA-TCPpromote ectopic bone
formation in vivo. (A) Sche-
matic overview of in vivo im-
plantation experiment. (B)
Histological analysis of newly
formed bone by MSCs on HA-
TCPand (C)MSCsonECMon
HA-TCP. Two sections/pellet,
four pellets/condition, in three
independent experiments were
analyzed and representative
sections are shown. Arrows in-
dicate the newly formed bone
stained in green by Masson–
Goldner staining on HA-TCP
(indicated as HA). Light pink
areas indicated unmineralized
bone and purple dots indicate
nuclei. Bars indicate 500mm
(left) and 100mm (right). (D)
Quantification of the newly
formedbonebyMSCsonECM
onHA-TCP andMSCs onHA-
TCP in each experiment. Three
independent experiments are
shown. Values: Average–
SEM of percentage bone/(HA-
TCP) in pellets per each ex-
periment. HA-TCP, hydroxy-
apatite and tricalcium
phosphate beta. Color images
available online at www
.liebertpub.com/tea
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The devitalized ECM showed high protein homology
with human bone samples
We have previously analyzed the composition of the
human bone proteome,23 showing 1213 proteins that were
shared by three human bone samples. Further analyses
lowered them down to 1200 unique proteins. This human
bone proteome was compared with the protein composition
of the in vitro cell-secreted ECM. More than 50% of the
ECM proteins were shared with the bone proteome, as 473
proteins out of 846 detected in the devitalized ECM were
also detected within the human bone samples (Fig. 6A).
Annexins such as ANXA2, ANXA6, ANXA5, ANXA1, and
vimentin (VIM) were within the most abundant proteins in
the ECM that were also detected in the bone proteome
(Supplementary Table S4).
Bioinformatic analysis of the shared proteins showed that
specific osteoblast- and ECM-related terms such as ‘‘adhesion
of cell-associated ECM,’’ ‘‘differentiation of osteoblasts,’’ and
‘‘proliferation of connective tissue cells,’’ were significantly
enriched (Fig. 6B), confirming the role of the protein com-
position of the ECM in mediating these effects. Proteins such
as trombospondin-1 (THBS1), VTN, and FN, but also intra-
cellular proteins such as integrins, were within the 473 shared
proteins, and were involved in ‘‘adhesion of cell-associated
matrix.’’ Moreover, proteins such as SPARC, COL1A1, and
fibulin-1 (FBLN1) were related to the proliferation of
connective tissue cells, whereas TNC, VIM, and Versican
were responsible for the differentiation of osteoblasts,
overall confirming the role of the ECM in mediating the
functional effects we observed (Supplementary Table S5).
Discussion
In this study, we successfully produced an osteopro-
motive human MSC-derived ECM, which was able to
accelerate the adhesion, proliferation, and osteogenic po-
tential of MSCs in vitro and to promote ectopic bone
formation in vivo. Known ECM components were detected
in the devitalized ECM, which also showed high homol-
ogy with the human bone protein composition. This vali-
dated our ECM model and provided insights into how the
ECM may modulate MSC behavior. Moreover, many un-
expected proteins not directly related to ECM structural
role were also detected.
Immediately after seeding on the ECM, MSCs formed
focal adhesion complexes that improved their adhesion to
the devitalized ECM. Extracellular proteins, such as FN,
COL1A1, VTN, and TNC, favor osteoblast adhesion to the
ECM by creating cell–matrix adhesion sites.6,20 The pro-
teomic analysis of the devitalized ECM identified FN,
COL1A1, and TNC within the most abundant proteins, and
other adhesive extracellular proteins, such as VTN and
FBLN1. Together this confirmed the presence of cell ad-
hesion promotors in the devitalized ECM, explaining the
accelerated cell attachment. Moreover, the devitalized ECM
was able to enhance the attachment of MSCs irrespectively
of their commitment, as less committed cells attached on the
ECM to a similar extent than the more committed cells.
One day on the devitalized ECM was already sufficient to
increase the percentage of proliferating MSCs, confirming
previous findings that used different cell-secreted ECMs to
enhance MSC proliferation.11–13,16 By analyzing the pro-
teomic composition of the ECM, we could successfully
detect FN, COL1A1, and SPARC, which have been shown
to promote osteoblast proliferation,22,32 and TNC, which
may mediate transforming growth factor beta (TGF-b) ac-
tion on bone formation.33 The percentage of proliferating
cells decreased over time as cells started to differentiate.
FIG. 5. Proteomic analysis of the ECM composition. (A)
A total of 846 proteins were detected by mass spectrometry;
35 were annotated as ‘‘extracellular matrix’’ GO term. Some
of the most relevant proteins are indicated. (B) Western blot
analysis of FN1, ALP, and ANXA2 (12 mg loaded) in the
devitalized ECM. GAPDH was used as loading control. (C)
Gene ontology (GO) analysis of the top 10% most abundant
detected proteins. (D) Most enriched pathways of GO
analysis of all the proteins detected in the ECM. Only the
significantly enriched terms are shown (Benjamini p < 0.01).
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The devitalized ECM induces a faster differentiation of
MSCs toward mineralizing osteoblasts as both ALP activity
and matrix mineralization were higher when MSCs were
cultured on the ECM. This observation is supported by pre-
vious findings showing in vitro cell-secreted ECMs that pro-
moted osteogenesis.14,15 The quicker adhesion to the known
osteogenic inducers that were detected in the ECM, such as
COL1A1, FN, collagen type XII alpha 1 (COL12A1), TNC,
VTN, and SPARC, might activate integrin-mediated signal-
ing pathways, increasing osteogenic differentiation.5,20,22,33,34
Annexins such as ANXA2, ANXA5, and ANXA6 were de-
tected in the devitalized matrix, along with previous find-
ings.17 Annexins are the initiators of mineralization and were
also detected within the most abundant proteins in human
bone samples, confirming the role of the devitalized ECM in
mimicking the osteogenic bone microenvironment.23,35
Despite the detection of initiators of mineralization such
as Annexins and ALP, the ECM has low ALP activity and
does not mineralize without further presence of living cells.
The necessity of living cells may be conceptually important
for the therapeutic application of devitalized ECM. If the
ECM mineralizes independently of living cells, this would
lead to uncontrolled mineralization, and may lead to path-
ological heterotopic mineralization. As osteoblast differen-
tiation and bone formation are complex processes in which
timing, order, and magnitude of events are important, in-
appropriate timing of mineralization thus may lead to an
inappropriate bone repair process.
Bone formation induced by ECM directly implanted
in vivo or by MSCs expanded on ECM ex vivo has shown
conflicting findings.10 We showed that the ECM promoted
in vivo ectopic bone formation by MSCs, inducing a higher
FIG. 6. Comparison of the
protein composition of the
devitalized ECM and the
human bone proteome. (A) A
total of 473 proteins were
shared between the devita-
lized ECM and the human
bone proteome. (B) In-
genuity pathway analysis of
the 473 proteins shared be-
tween the devitalized ECM
and the human bone samples.
Represented proteins lead to
the significant enrichment of
functional annotations such
as ‘‘proliferation of connec-
tive tissue cells’’ ( p = 3.81
E-09), ‘‘differentiation of
osteoblasts’’ ( p = 6.44 E-07),
and ‘‘adhesion to cell-
associated matrix’’ ( p = 1.89
E-06) (bold: proteins high-
lighted in the text).
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amount of bone than by MSCs alone. Probably the role of
ECM is decisive to stimulate a robust formation of bone.
However, further experiments are needed to increase the
sample size and diminish the heterogeneity to overcome the
biological variation. Based on our current observations, we
propose that with any given MSC preparation, one may or
may not observe bone formation, whereas in the presence of
the ECM we produced, bone formation will be observed
with all MSC preparations. In other words, the presence of
the ECM seemed to reduce variation in the amount of bone
formed over different experiments.
Structural ECM proteins and known components of the
bone marrow niche, such as COL1A1, FN, VTN, and TNC,
were successfully detected among the most abundant pro-
teins in the ECM, along with previous findings.12,16–18
However, also inhibitors of mineralization were detected,
such as alpha-2-HS-glycoprotein, which is found in the
mineralized bone but also acts as inhibitor of ectopic cal-
cification.36 Interestingly, GFs such as BMPs and TGF-b
could not be detected in the ECM, which may be attributed
to the sensitivity of the technique or to the devitalization
procedure. Despite the absence of GFs, we unequivocally
show that the matrix influenced MSC behavior. Probably,
ECM remodeling takes place, releasing GFs that were en-
trapped in the ECM. Indeed, protease inhibitors such as
cystatin C (CST3) were detected, but also proteinases, such
as matrix metalloproteinase 14 (MMP14), which are known
to promote osteogenic differentiation.37,38
Notably, many proteins detected in the devitalized matrix
were annotated as cytoplasmic or plasma membrane bound.
Cell remnants most likely arose from cell lysis during the
freeze–thaw cycling and were resistant to the extensive
washings.10 Nevertheless, we should consider that the ECM
composition in its entirety was responsible for the effects
described in this study; these proteins enriched the matrix
composition, playing a central role with the known ECM
proteins.
As >50% proteins were shared between the devitalized
ECM and the human bone samples, we thus show that our
natural ECM model is representative of the in vivo dynamic
bone microenvironment. Following this, cell remnants may
have a functional role as remnants arising from osteoblasts
undergoing apoptosis. These are present in the bone and
bone marrow and stimulate efferocytosis by osteal macro-
phages, which are key regulators of bone homeostasis and
wound repair.39 Therefore, the cell remnants detected in the
devitalized ECM could implement the supportive role of
stromal cells and thereby the ECM we produced may rep-
resent a more complete environment than just the well-
known ECM proteins. However, further studies are needed
to unravel new functions for the ECM in the context of
osteoimmunology.
We unexpectedly detected many proteins related to mi-
tochondrial functions and structure in the devitalized matrix.
Nevertheless, we show that the devitalized matrix is meta-
bolically inactive. As the osteogenic differentiation is a
high-energy demanding process, we believe that these pro-
teins arise from lysis of the ECM-secreting MSCs, as the
devitalization occurred before the onset of mineralization
and might be related to energy metabolism function.
GO analysis of the proteins detected in the ECM revealed
also GO terms that were not directly related to known ECM
functions, thus broadening the spectrum of the devitalized
ECM functions. For instance, ‘‘antioxidant activity’’ ap-
peared as an enriched GO term, with proteins such as su-
peroxide dismutase 1 that was previously detected in the
human bone microenvironment.23 As the ECM has been
already proposed to reduce MSC aging,13 the antioxidant
function of the devitalized matrix should be further inves-
tigated to improve ex vivo cultures for clinical applications.
The most abundant proteins detected in the matrix were
also related to angiogenesis and vasculature remodeling,
showing interesting functions of the ECM. Indeed, among
these proteins, TNC is mitogenic for hematopoietic stem
cells (HSCs) in HSC niche,40 and COL1A1 is involved in
vasculature remodeling.41 Our findings support the idea of
using the matrix for HSC expansion.16
The role of ECM in modulating MSC behavior has been
successfully investigated in many studies using cell-secreted
ECMs, which have been obtained by different decellular-
ization techniques. Although the freeze–thaw cycles ap-
proach has been shown to damage the fibrillary structure of
ECM,42 and not removing all cell remnants, this method
also allowed successful production of cell-derived ECMs on
scaffolds and maintain most of the ECM components.10,14,43
Along with these latter findings, we believe that the model
of devitalized ECM presented here represents a simpler way
to produce a matrix in vitro by using cost-effective freeze–
thaw cycling, while still being able to accelerate and improve
the osteogenic potential of MSCs as shown.
In summary, we produced an osteoblast-derived ECM by
a simple devitalization treatment; this in vitro model of
bone ECM improved the osteogenic potential of MSCs,
reinforcing previous findings. This, combined with the
increase in cell proliferation could be useful to expand
autologous MSCs ex vivo and improve their use for bone
regeneration.
A detailed proteomic analysis revealed known ECM
components responsible for the observed effects and an
overlap with the human bone microenvironment, but also
novel ECM functions that need further investigation. Some
candidate proteins could be overexpressed in ECM-secreting
MSCs, to produce a tailor-made ECM that improves MSC
properties to accelerate fracture healing, broadening the
future applications of the cell-secreted ECM. In addition,
MSCs could be isolated from patients to easily produce an
autologous ECM, to improve patient-specific therapies.
Overall, the devitalized ECM could be applied as natural
biomaterial that mimics the osteogenic niche and to func-
tionalize scaffolds to develop osteoinductive materials for
the implanted cells in vivo, to robustly accelerate bone
regeneration.
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